Assessment of the Serum Level of Interleukin-6 and Interleukin-10 in Newly Diagnosed Acute Myeloid Leukemia Patients and the Response to Induction Chemotherapy - Egyptian Knowledge Bank - troweb

56362

Assessment of the Serum Level of Interleukin-6 and Interleukin-10 in Newly Diagnosed Acute Myeloid Leukemia Patients and the Response to Induction Chemotherapy

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

A STUDY OF SERUM IMMUNOGLOBULIN LEVELS IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING STANDARD INDUCTION CHEMOTHERAPY

Article

Prognostic Value of Interleukin-17 A Gene Polymorphism and Serum IL-17 Levels in Adult Acute Myeloid Leukaemia Patients

Article

Prognostic value of Elevated Serum Inflammatory Markers in Adult Patients receiving Induction Chemotherapy for Acute Leukemia

Article

Assessment of IL6 and TNF α in Chronic Lymphocytic Leukemia

Article

Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma

Article

Assessment of Interleukin 27 Serum Levels and Echocardiographic Parameters in Children and Adolescents with Type 1 Diabetes Mellitus

Article

INTERLEUKIN 3 RECEPTOR (CD123) EXPRESSION IN ACUTE MYELOID LEUKAEMIA PATIENTS IN RELATION TO DISEASE CHARACTERISTICS AND TREATMENT OUTCOME

Article

Assessment of Interleukin (8) in Type 2 Diabetes Mellitus

Article

IL‑17F and IL- 23 gene polymorphism in patients with acute myeloid leukemia, an Egyptian study

Article

Assessment of Interleukin-34 Serum level In Children with Systemic lupus Erythematosus